Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Low Energy Prosoft 2.0¿¡ ÀÇÇÑ Transurethral Microwave Thermotherapy (TUMT)ÀÇ ÀÓ»ó°æÇè Long-term follow up of Transurethral Microwave Thermotherapy (TUMT) with Low Energy Prosoft 2.0

´ëÇѺñ´¢±â°úÇÐȸÁö 1997³â 38±Ç 4È£ p.363 ~ 367
ÀÌdz±Ô, ÃÖ³«±Ô,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌdz±Ô (  ) 
ÇѾç´ëÇб³

ÃÖ³«±Ô (  ) 
ÇѸ²´ë

Abstract


From August 1991 to July 1992, 262 patients of benign prostatic hyperplasia (BPH) were treated with transurethral microwave thermotherapy (TUMT). Among those, 64 patients were followed up more than 1 year and 26 patients were followed up more
than
4
years without other treatment.
The patient's age ranged from 49 to 80 years with a mean of 64.3 years. Prostate volume determined by transrectal ultrasonography ranged from 27.0§¨ to 73.6§¨, the mean 40.8§¨.
After 1 year, maximum flow rate increased from 8.1¡¾2.3ml/sec to 11.5¡¾3.6ml/sec, Madsen symptom score decreased from 12.6¡¾3.8 to 6.6¡¾4.7, and residual urine volume decreased from 75.6¡¾33.5ml to 43.4¡¾35.3ml. Complete response of maximum flow
rate
and Madsen symptom score observed in 17.2% in each group, partial response in 50.0% and 40.6%, and non-response in 32.8% and 42.2%. Improvement of subjective symptoms were evaluated by patients themselves and divided into 3 group: "satisfactory"
was
28.1%, "acceptable" 34.4%,and "not effective" 37.5%. Complications were 1 case of erectile dysfunction and 4 cases of dry ejaculation.
Among the 64 patients who were followed up more than 1 year, 26 patients (40.6%) were remained without other treatment, 20 (3.13%) patients were medicated additionally, 11 (17.2%) patients required TUR-P during the follow-up period due to
persistent
symptoms, and 7(10.9%) patients were performed re-TUMT.
In conclusion, TUMT could be useful, safe and inexpensive treatment for BPH when it is applied selectively and should be advanced in mechanism to be more effective in treatment of BPH.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS